Surgical Ablation for Atrial Fibrillation: Risk Factors for Recurrence and Long-Term Outcome.

atrial fibrillation long-term follow-up surgical ablation

Journal

Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208

Informations de publication

Date de publication:
12 Apr 2024
Historique:
received: 30 10 2023
revised: 23 01 2024
accepted: 10 04 2024
medline: 23 6 2024
pubmed: 23 6 2024
entrez: 22 6 2024
Statut: aheadofprint

Résumé

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Due to the insufficient efficacy of antiarrhythmic drugs and their adverse side effects, there has been considerable interest in the interventional treatment of AF, including both catheter ablation and surgical ablation. Surgical ablation or the maze procedure is a treatment option for patients with AF undergoing concomitant or isolated cardiac surgery. We performed a retrospective study of prospectively collected data to investigate short- and long-term outcomes of patients who underwent the surgical ablation of AF. Outcome variables included freedom from recurrent atrial arrhythmias and mortality at 1-, 3-, 5-, and 7-year follow-ups. We also identified risk factors for arrhythmia recurrence and mortality. Israel's largest university tertiary care center. The study population comprised 668 patients operated on between January 1, 2006, and June 30, 2022. All patient data were extracted from our departmental database. Concomitant or stand-alone surgical AF ablation. The mean duration of follow-up was 106 ± 66.7 months. Freedom from AF was 97.6% (n = 615) and mortality was 3% (n = 20) at the 1-year follow-up, 95.3% (n = 574) and 6.1% (n = 45) at 3 years, 90.1% (n = 396) and 9.1% (n = 61) at 5 years, and 77.5% (n = 308) and 10.8% (n = 72) at 7 years. According to logistic regression analysis, age and female sex determined the 7-year freedom from AF, and risk factors for 7-year mortality included diabetes mellitus, age, and valve surgery. Surgical ablation had a high success rate, with freedom from recurrent atrial arrhythmia at 1-, 3-, 5-, and 7-year follow-ups. Age and female sex were factors determining the 5- and 7-year recurrence of AF.

Identifiants

pubmed: 38908935
pii: S1053-0770(24)00273-8
doi: 10.1053/j.jvca.2024.04.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jonathan Frogel (J)

Department of Anesthesiology, Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Alexander Kogan (A)

Department of Anesthesiology, Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel; Department of Cardiac Surgery, Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: Alexander.Kogan@sheba.health.gov.il.

John G Augoustides (JG)

Department of Anesthesiology and Critical Care Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.

Tamer Jamal (T)

Department of Cardiac Surgery, Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Nir Shimoni (N)

Department of Anesthesiology, Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel; Department of Cardiac Surgery, Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Roni Postan-Koren (R)

Department of Cardiac Surgery, Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Viktoriia Ivanov (V)

Department of Anesthesiology, Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Avi Sabbag (A)

Division of Cardiology, Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ehud Raanani (E)

Department of Cardiac Surgery, Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Leonid Sternik (L)

Department of Cardiac Surgery, Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Classifications MeSH